Inspira™ Technologies to Participate in Upcoming Events in May
Inspira Technologies OXY B.H.N.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) has announced its participation in several key events in May 2022, showcasing its innovative respiratory support technology. Highlights include the Medtech Forum in Barcelona from May 3-5, featuring VP Adi Rizansky Nir, and the EuroELSO Congress in London from May 4-6, with CTO Daniella Yeheskely-Hayon. The company will also present at the Sidoti Virtual Microcap Conference on May 11 and engage in a Fireside Chat at the Benzinga Virtual All Access Show on May 20, led by CFO Joe Hayon.
The company’s ART device aims to support respiratory patients efficiently.
Details
News Market Reaction – IINN
The recorded move for IINN in the trading session of this news was -0.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RA'ANANA, Israel, May 3, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, today announced that the Company will participate in the following events in May:
The Medtech Forum 2022
Format: one-on-one meetings
When: May 3-5
Where: Barcelona International Convention Center, Barcelona, Spain
Who: Dr. Adi Rizansky Nir, VP of Business Development of Inspira Technologies
The 10th EuroELSO Congress 2022
Format: workshops and one-on-one meetings
When: May 4-6
Where: Queen Elizabeth II Centre, London, UK
Who: Dr. Daniella Yeheskely-Hayon, CTO of Inspira Technologies
Dr. Adi Rizansky Nir, VP of Business Development of Inspira Technologies
Mr. Tomer Carmeli, Product Manager of Inspira Technologies
Sidoti Virtual Microcap Conference
Format: Virtual presentation and one-on-one meetings
When: Presentation at 12:15pm ET on May 11
Who: Joe Hayon, president, co-founder & CFO of Inspira Technologies
Benzinga Virtual All Access Show
Format: Virtual Fireside Chat
When: May 20 at 11:00am ET
Who: Joe Hayon, president, co-founder & CFO of Inspira Technologies
Abut Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies is an innovative medical device company in the respiratory care industry. Inspira Technologies is developing the ART device, a cost effective early extracorporeal respiratory support system with an intent to function as an "Artificial Lung" for deteriorating respiratory patients. The ART device designed to utilize a hemo-protective flow approach aimed to rebalance saturation levels while patients are awake and breathing, potentially minimizing the patient's need for mechanical ventilation. The Company's product has not yet been tested or used in humans and has not been approved by the U.S. Food and Drug Administration (FDA).
For more information, please visit our corporate website: www.inspirao2.com
For more details:
Miri Segal, Investor Relations, MS-IR LLC
+917-607-8654, msegal@ms-ir.com
MRK-ARS-024
Copyright © 2018-2022 Inspira Technologies OXY B.H.N. LTD., All rights reserved.
View original content:https://www.prnewswire.com/news-releases/inspira-technologies-to-participate-in-upcoming-events-in-may-301538469.html
SOURCE Inspira Technologies
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.